RIZWAN MUFTI: Open Payments
NPI 1790739365 · LATHRUP VILLAGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 19 payments from 10 companies in 2025. Trend: 2023 $642 · 2024 $459 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $88 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Eisai Inc. | 2 | $56 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Alkermes, Inc. | 1 | $25 |
| Neuronetics, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, FANAPT, Leqembi, REXULTI, AUSTEDO XR, ABILIFY MAINTENA, ARISTADA, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across MI — which companies pay providers there.
